Wyeth Targets Zydus In New Effexor XR Patent Suit
In its latest effort to block a generic version of Effexor XR, Wyeth has accused Indian drugmaker Cadila Healthcare Ltd. and its U.S.-based subsidiary, Zydus Pharmaceuticals USA Inc., of infringing three...To view the full article, register now.
Already a subscriber? Click here to view full article